Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M. M. Uhrich"'
Autor:
McClellan M. Walther, R V LaRocca, Michael R. Cooper, M M Uhrich, P. L. Choyke, Seth M. Steinberg, Cy A. Stein, Nancy A. Dawson, G Weiss, Charles E. Myers
Publikováno v:
Journal of Clinical Oncology. 10:881-889
PURPOSE Suramin is known to inhibit the growth of malignant prostate carcinoma cells in vitro. This led us to evaluate the effectiveness of suramin in the treatment of 38 patients with prostate carcinoma refractory to hormone therapy. PATIENTS AND ME
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4500a5c8b35f919ee1abe8cb3eb960bf
https://doi.org/10.1200/jco.1992.10.6.881
https://doi.org/10.1200/jco.1992.10.6.881
Publikováno v:
Journal of Clinical Oncology. 27:6602-6602
6602 Background: PRC is critical to care, treatment, and decision-making for advanced cancer patients (ACP). Deficits in oncologists’ (MDs) PRC have previously been identified. The role oncology nurses (RNs) play in PRC and their views and experien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20ac9bab95a6c5a4de87f674e09f4326
https://doi.org/10.1200/jco.2009.27.15_suppl.6602
https://doi.org/10.1200/jco.2009.27.15_suppl.6602
Autor:
Edelman MJ; Division of Hematology/Oncology, University of California-Davis, Sacramento, California, USA., Gandara DR, Meyers FJ, Ishii R, O'Mahony M, Uhrich M, Lauder I, Houston J, Gietzen DW
Publikováno v:
Cancer [Cancer] 1999 Aug 15; Vol. 86 (4), pp. 684-8.
Autor:
Edelman MJ; Division of Hematology and Oncology, University of California, Davis School of Medicine, Sacramento, USA., Gandara DR, Perez EA, Lau D, Lauder I, Turrell C, Uhrich M, Meyers F
Publikováno v:
Investigational new drugs [Invest New Drugs] 1998; Vol. 16 (1), pp. 69-75.
Autor:
Lara PN Jr; University of California Davis Cancer Center, Sacramento 95817, USA., Gandara DR, Wurz GT, Lau D, Uhrich M, Turrell C, Raschko J, Edelman MJ, Synold T, Doroshow J, Muggia F, Perez EA, DeGregorio M
Publikováno v:
Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 1998; Vol. 42 (6), pp. 504-8.
Autor:
La Rocca RV; Clinical Pharmacology Branch, National Cancer Institute, Bethesda, Maryland., Cooper MR, Stein CA, Kohler D, Uhrich M, Weinberger E, Myers CE
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 1992 Jul; Vol. 3 (7), pp. 571-3.
Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation.
Autor:
LaRocca RV; Medicine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Cooper MR, Uhrich M, Danesi R, Walther MM, Linehan WM, Myers CE
Publikováno v:
The Urologic clinics of North America [Urol Clin North Am] 1991 Feb; Vol. 18 (1), pp. 123-9.